Flex-nucleoside analogues – Novel therapeutics against filoviruses
| dc.contributor.author | Yates, Mary Kendall | |
| dc.contributor.author | Raje, Mithun R. | |
| dc.contributor.author | Chatterjee, Payel | |
| dc.contributor.author | Spiropoulou, Christina F. | |
| dc.contributor.author | Bavari, Sina | |
| dc.contributor.author | Flint, Mike | |
| dc.contributor.author | Soloveva, Veronica | |
| dc.contributor.author | Seley-Radtke, Katherine | |
| dc.date.accessioned | 2025-07-30T19:22:40Z | |
| dc.date.issued | 2017-04-21 | |
| dc.description.abstract | Fleximers, a novel type of flexible nucleoside that have garnered attention due to their unprecedented activity against human coronaviruses, have now exhibited highly promising levels of activity against filoviruses. The Flex-nucleoside was the most potent against recombinant Ebola virus in Huh7 cells with an EC₅₀=2μM, while the McGuigan prodrug was most active against Sudan virus-infected HeLa cells with an EC₅₀ of 7μM. | |
| dc.description.sponsorship | This work was supported by the National Institutes of Health - T32 GM066706 and R21 AI097685 (KSR). We would also like to thank USAMRIID/MTS colleagues Dima Gharaibeh, Ylenia Cau, Tara Kenny, Cary Retterer, Rouzbeh Zamani, Glenn Gomba and Collin Dube for assistance. Work at USAMRIID was funded by The Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) of the Defense Threat Reduction Agency (DTRA). | |
| dc.description.uri | https://www.sciencedirect.com/science/article/pii/S0960894X17304456?via%3Dihub | |
| dc.format.extent | 5 pages | |
| dc.genre | journal articles | |
| dc.genre | postprints | |
| dc.identifier | doi:10.13016/m2lvxf-fuy0 | |
| dc.identifier.citation | Yates, Mary K., Mithun R. Raje, Payel Chatterjee, Christina F. Spiropoulou, Sina Bavari, Mike Flint, Veronica Soloveva, and Katherine L. Seley-Radtke. “Flex-Nucleoside Analogues – Novel Therapeutics against Filoviruses.” Bioorganic & Medicinal Chemistry Letters 27, no. 12 (June 15, 2017): 2800–2802. https://doi.org/10.1016/j.bmcl.2017.04.069. | |
| dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2017.04.069 | |
| dc.identifier.uri | http://hdl.handle.net/11603/39581 | |
| dc.language.iso | en_US | |
| dc.publisher | Elsevier | |
| dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
| dc.relation.ispartof | UMBC Student Collection | |
| dc.relation.ispartof | UMBC Chemistry & Biochemistry Department | |
| dc.relation.ispartof | UMBC Faculty Collection | |
| dc.relation.ispartof | UMBC Graduate School | |
| dc.rights | Creative Commons Attribution Non-Commercial No Derivatives License | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en | |
| dc.subject | Filovirus | |
| dc.subject | Nucleoside | |
| dc.subject | Fleximers | |
| dc.subject | Antiviral | |
| dc.subject | Ebola | |
| dc.title | Flex-nucleoside analogues – Novel therapeutics against filoviruses | |
| dc.type | Text | |
| dcterms.creator | https://orcid.org/0000-0002-0154-3459 |
